Stilla Technologies
Edit

Stilla Technologies

https://www.stillatechnologies.com/
Last activity: 14.02.2024
Active
Categories: AnalyticsBioTechContent DistributionDataDevelopmentEnvironmentalFoodTechMarketResearchTechnology
Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability
Followers
487
Mentions
13
Location: United States, Massachusetts, Boston
Total raised: $75.12M
Founded date: 2013

Investors 6

Funding Rounds 3

DateSeriesAmountInvestors
24.11.2021-$35.08M-
11.02.2020Series B$21.84M-
20.11.2018Series A$18.2MIllumina V...

Mentions in press and media 13

DateTitleDescription
14.02.2024Skanska invests PLN 126M, about SEK 330M, in the residential project Stilla in Warsaw, PolandSkanska invests PLN 126M, about SEK 330M, in the residential project Stilla in Warsaw, Poland Wed, Feb 14, 2024 07:30 CET Report this content Skanska invests PLN 126M, about SEK 330M, in the residential project Stilla in Warsaw, Poland. The...
07.04.2022TATAA Biocenter Expands Digital PCR Service Offering with Stilla’s 6-Color naica® systemTATAA Biocenter Expands Digital PCR Service Offering with Stilla’s 6-Color naica® system Thu, Apr 07, 2022 07:30 CET Report this content Today TATAA Biocenter, Europe’s leading provider of molecular analysis services, announced it is adding...
24.11.2021Stilla Technologies Secures More Than €31M in FundingStilla Technologies, a Villejuif, France and Beverly, MA-based multiplex digital PCR company, raised €31.3m in funding. The round included: €11.3 million of convertible bonds; and €20m in loan financing. In addition to new funding from exis...
28.07.2021Stilla Launches Access Program for Industry's First Six-Color Digital PCR SystemStilla Technologies, the company innovating the next generation of digital PCR solutions for life science research and molecular diagnostics, is pleased to announce the launch of its 6-Color Digital PCR Access Program which enables early ac...
03.08.2020Stilla Technologies Leverages Funding to Advance dPCR TechnologyIn the last twenty years, digital polymerase chain reaction (dPCR) technology has given hopes to have potential applications in genetic engineering, cell biology and medical diagnostics. In this context, Paris, France‐based life sciences co...
11.02.2020Stilla Technologies Raises €20M in Series B FundingStilla Technologies, a Paris, France-based provider of digital PCR (dPCR) solutions for high-precision genetic analysis, raised €20m ($22m) in Series B funding. The round was led by TUS-Holdings, with participation from existing investors I...
26.11.2018Illumina Ventures leads €16M round for digital PCR firm Stilla TechnologiesIllumina Ventures led a €16 million ($18 million) series A round for Stilla Technologies, a Paris-based developer of digital PCR solutions for genetic analysis. The genomics-focused fund supported by Illumina was joined by Kurma Partners, L...
26.11.2018Illumina Ventures leads €16M round for digital PCR firm Stilla Technologies W h i t e p a p e r Vital Precision for Cost Reduction, QA, and Regulatory ComplianceIllumina Ventures led a €16 million ($18 million) series A round for Stilla Technologies, a Paris-based developer of digital PCR solutions for genetic analysis. Sponsored by Agilent Technologies How would you like to win free bench space at...
20.11.2018Stilla Technologies Completes €16M Series A FinancingStilla Technologies, a Paris, France-based provider of digital PCR solutions for high precision genetic analysis, completed a Series A financing round of €16m. The round was led by Illumina Ventures, with participation from Kurma Partners, ...
20.11.2018Daily funding roundup - November 20th, 2018Jump Technologies raised $2M; Enboarder raised $4M; Alcide raised $7M; Item 9 Labs raised $7.7M Jump Technologies: Jump Technologies, Inc. has innovated new solutions in areas including mobile inventory management, replenishment, procuremen...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In